Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3801 Miranda Ave
Palo Alto, CA 94304Phone+1 650-493-5000Fax+1 650-849-1213- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1975 - 1977
- University of California (San Francisco)Residency, Internal Medicine, 1974 - 1975
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1972 - 1974
- Washington University in St. Louis School of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1974 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
Clinical Trials
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer Start of enrollment: 2004 Apr 01
Publications & Presentations
PubMed
- 20 citationsDouble-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial o...Aarti K. Bhatia, Ju Whei Lee, Harlan A. Pinto, Charlotte Jacobs, Paul J. Limburg, Philip Rubin, Robert M. Arusell, Eamonn Patrick Dunphy, Janardan D. Khandekar, Seth A...> ;Cancer. 2017 Dec 1
- A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate ...Chi KN, Yu EY, Jacobs C, Bazov J, Kollmannsberger C, Higano CS, Mukherjee SD, Gleave ME, Stewart PS, Hotte SJ> ;Ann. Oncol.. 2016-06-01
- Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.Ibrahim MFK, Mazzarello S, Shorr R, Vandermeer L, Jacobs C, Hilton J, Hutton B, Clemons M> ;Ann. Oncol.. 2015-11-01
- Join now to see all
Grant Support
- Bexarotene In Combination With Iressa In Treatment Of Non-Small Cell Lung CancerNational Center For Research Resources2006
- Stanford University Participation In The NCOGNational Cancer Institute1985–1986
- Day Care Center--CoreNational Cancer Institute1985
Professional Memberships
- Fellow
Hospital Affiliations
- Stanford Health CarePalo Alto, California
- VA Palo Alto Heath CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: